Causes and Risk Factors
The strongest driver is chronic acid reflux. Factors that increase the likelihood of Barrett's esophagus include:- Long-standing GERD: Years of gastroesophageal reflux disease is the central risk factor, although some people with Barrett's have few reflux symptoms.
- Hiatal hernia: When part of the stomach slides above the diaphragm, the valve between esophagus and stomach works less effectively, worsening acid exposure.
- Male sex and age over 50: Barrett's is diagnosed most often in middle-aged and older men.
- Central obesity: Weight carried around the abdomen increases reflux.
- Smoking: Raises the risk of both Barrett's and esophageal cancer.
- Family history: Barrett's esophagus and esophageal cancer in close relatives increase risk.
Symptoms
Barrett's esophagus itself causes no symptoms — the tissue change is silent. Most people come to diagnosis because of reflux symptoms such as frequent heartburn, regurgitation, or throat irritation similar to laryngopharyngeal reflux. Warning symptoms that should prompt urgent evaluation include difficulty or pain with swallowing, food sticking, unintended weight loss, vomiting blood, or black tarry stools. Notably, some people find their heartburn actually fades over the years because the specialized lining is less sensitive to acid — so improving symptoms do not necessarily mean the esophagus has healed.Diagnosis
The only way to diagnose Barrett's esophagus is with an upper endoscopy, during which the physician sees the characteristic salmon-colored lining and takes biopsies. The same examination evaluates for related problems such as esophageal inflammation, ulcers, and gastritis. The biopsies are graded for dysplasia — precancerous cell changes — as none, low-grade, or high-grade, and this grading drives all subsequent management. Screening endoscopy is often suggested for people with chronic reflux plus several of the risk factors above.Treatment and Monitoring
- Acid suppression: Daily proton pump inhibitor therapy — omeprazole, esomeprazole, or pantoprazole — controls reflux symptoms and reduces ongoing acid injury to the esophagus.
- Lifestyle measures: Weight loss when appropriate, not smoking, limiting alcohol, smaller evening meals, and elevating the head of the bed all support acid control.
- Surveillance endoscopy: When there is no dysplasia, endoscopy is typically repeated every three to five years to watch for change. Sticking to the recommended schedule matters, because dysplasia found early is very treatable.
- Endoscopic treatment of dysplasia: Confirmed low-grade or high-grade dysplasia is usually treated endoscopically — most often with radiofrequency ablation to destroy the abnormal lining, or endoscopic resection of raised areas — which is highly effective at preventing progression to cancer.
When to Seek Care
Contact a doctor promptly if you develop trouble swallowing, food impaction, unexplained weight loss, or signs of bleeding such as black stools. These symptoms need timely endoscopic evaluation. A Barrett's diagnosis is a reason for structured follow-up, not alarm. The internal-medicine team at Zimmer Medical Group can optimize your reflux treatment, coordinate surveillance endoscopies, and keep your monitoring on schedule.Living With Barrett's Esophagus
Barrett's esophagus is a change in the lining of the lower oesophagus, where normal squamous cells are replaced by intestinal-type cells after years of acid exposure. The change itself causes no symptoms — people notice reflux, not Barrett's — and it is found on endoscopy done for reflux that has been present for years.
What the risk actually is
Barrett's is a risk factor for oesophageal adenocarcinoma, and that is why it is monitored. But the annual risk of progression from Barrett's without dysplasia to cancer is low — well under one percent per year — and the large majority of people with Barrett's never develop cancer. Understanding that proportion matters, because the diagnosis is frequently heard as a cancer diagnosis rather than as a reason for surveillance.
Surveillance is the point
Periodic endoscopy with biopsies detects dysplasia — precancerous change — at a stage where it can be treated endoscopically rather than surgically. Intervals depend on whether dysplasia is present and its grade, typically every three to five years without dysplasia and considerably more often with it. Radiofrequency ablation is highly effective for dysplastic Barrett's and has changed the outlook substantially over the past two decades.
Acid control continues regardless of symptoms
Proton pump inhibitor therapy is generally continued long term in Barrett's, and this is one of the clearer indications for indefinite acid suppression — unlike uncomplicated reflux, where step-down should be attempted. Symptom control is not the measure: many people with Barrett's have relatively mild reflux symptoms, sometimes because the altered lining is less sensitive. Weight loss, avoiding food within three hours of lying down, and elevating the head of the bed all help. Our gastroenterology team manages surveillance, and the GERD page and long-term PPI article cover the related decisions. The NIDDK Barrett's resource and National Cancer Institute provide further detail.
What raises the risk of progression
Longer segments of affected lining, ongoing uncontrolled reflux, smoking, central obesity, male sex, and older age all increase the chance of progression. Several of these are modifiable, which means surveillance is not the only thing influencing the outcome — weight loss and smoking cessation change the trajectory rather than merely the monitoring interval.
If you have Barrett's and are unsure when your next endoscopy is due, or your reflux is not controlled, contact us to review the plan.